Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results